In terms of scRNA-seq data, PD1, PDL1 and PDL2 were highly expressed in type I GBM cells, whereas CTLA4, CD80 and CD86 were highly expressed in type II GBM cells (Figure 6A). Here, CTLA4 is linked to glioblastoma.